Selank

Resumen del Protocolo

Resumen conciso del once‑daily anxiolytic/nootropic regimen.

• Objetivo:Support reduction of anxiety and neurasthenia symptoms while providing anti-asthenic (energy-boosting) benefits.
• Programa:Inyecciones subcutáneas diarias por 4-semana cycles with 4-semana breaks (8–16 semanas total protocol).
• Rango de dosis:300–500 mcg daily with gradual titration.
• Reconstitución:3.0 mL por vial de 10 mg (~3.33 mg/mL) para medidas precisas de unidades.
• Almacenamiento:Lyophilized frozen; reconstituted refrigerated; evitar congelar–thaw.

Protocolo de Dosis

Enfoque de dosis diaria sugerido.

• Inicio:300 mcg diarias durante semanas 1–2; clinicians treating cognitive or anxiety issues often begin at this level.
• Dosis Objetivo:500 mcg daily by semanas 3–4 if lower doses are well-tolerated.
• Frecuencia:Una vez al día (subcutáneo); some protocols use 5 días per semana with 2-day breaks.
• Cycle Pattern:4 semanas on, 4 semanas off to prevent tachyphylaxis; repeat as needed.
• Momento de aplicación:Any consistent time; rotar sitio de inyeccións to prevent irritación.

Pasos para Reconstituir

• Extraer3.0 mLde agua bacteriostática con una jeringa estéril.
• Inyectar lentamente por la pared del vial; evitar que haga espuma.
• Gently swirl/roll until dissolved (do not shake vigorously as peptides are delicate).
• Label and refrigerate at2–8 °C (35.6–46.4 °F), protegido de la luz.

Posibles Beneficios

Observations from clinical and preclinical literature.

• Produces anxiolytic effects comparable to benzodiazepines in human ensayos clínicos without sedation or dependence risk.
• Provides anti-asthenic (energy-boosting) benefits alongside anxiety reduction.
• Induces lasting neurobehavioral changes; primate studies showed elimination of fear/anxiety behaviors with long-term stabilizing effects.
• Generally well tolerated in estudios clínicos; a 14-day continuous course was well-tolerated and effective in human trials.
• Leves y ocasionales inyectarion-site reactions (redness, minor irritación) pueden ocurrir con administración subcutánea; proper site rotation minimizes this risk.
• Lacks sedative side effects typical of classical anxiolytics, allowing for daytime use without impairment.
• Has been explored at higher doses for experimental applications such as attenuating opioid withdrawal symptoms, indicating a wide therapeutic range.